Hikal Limited

NSE:HIKAL.NS

380.5 (INR) • At close September 18, 2024
Bedrijfsnaam Hikal Limited
Symbool HIKAL.NS
Munteenheid INR
Prijs 380.5
Beurswaarde 46,916,030,500
Dividendpercentage 0.42%
52-weken bereik 250.1 - 410.9
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Jai Vishwanath Hiremath
Website https://www.hikal.com

An error occurred while fetching data.

Over Hikal Limited

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment

Vergelijkbare Aandelen

Glenmark Life Sciences Limited logo

Glenmark Life Sciences Limited

GLS.NS

1,271.65 INR

FDC Limited logo

FDC Limited

FDC.NS

582.4 INR

Vijaya Diagnostic Centre Limited logo

Vijaya Diagnostic Centre Limited

VIJAYA.NS

903.3 INR

Caplin Point Laboratories Limited logo

Caplin Point Laboratories Limited

CAPLIPOINT.NS

1,965.5 INR

Aarti Drugs Limited logo

Aarti Drugs Limited

AARTIDRUGS.NS

525.3 INR

HealthCare Global Enterprises Limited logo

HealthCare Global Enterprises Limited

HCG.NS

411.7 INR

Wockhardt Limited logo

Wockhardt Limited

WOCKPHARMA.NS

957.85 INR

Shilpa Medicare Limited logo

Shilpa Medicare Limited

SHILPAMED.NS

901.9 INR

Sun Pharma Advanced Research Company Limited logo

Sun Pharma Advanced Research Company Limited

SPARC.NS

219.74 INR

Tarsons Products Limited logo

Tarsons Products Limited

TARSONS.NS

485.2 INR

Financiële Gegevens

Cijfers zijn in miljoenen (INR)

Cijfers zijn in miljoenen (INR)